Chc Healthcare Group · TWSE:4164
Chc Healthcare — 2017 Institutional Investor Conference
41 slides from Chc Healthcare's conference presentation, May 24, 2017
Slide 1: 2017 Institutional Investor Conference
2017 Institutional Investor Conference 4164 TT
Slide 2: Disclaimer
Disclaimer • The information contained in this confidential document ("Presentation") has been prepared by CHC Healthcare Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment. • While the information contained herein has been prepa
Slide 3: Agenda: Company Overview, Operational Results, Future Guidance
Company Operational Future Q&A Overview Results Guidance 3
Slide 4: Company Overview
Company Operational Future Q&A Overview Results Guidance 4
Slide 5: Company Introduction
Company Introduction • Name : CHC Healthcare Group (4164 TT) • Date of Establish : 2009/11/27 (First subsidiary, Chiu Ho Medical, was founded on 1977/08/12.) • Chairman : Mr. Lee Pei-Lin • Headquarters : Taipei • Branches : Taichung, Kaohsiung, Beijing & Guangzhou • Major Business : Providing Medica
Slide 6: Company Milestones
Company Milestones 2016 • IBA first official direct selling contract signed 2014 in Taiwan 2012 • Greater China • Announce entering Sole Distributor Taiwan’s long-term • Listed in TWSE for Novadaq care market 2009 Stock Exchange on Oct 24, 2012 1999 • Founded CHC Healthcare Group • Install the first
Slide 7: Management Team
Management Team China Taiwan Goung-Yu, Chen General Manager Ming-Lun, Lee Vice President Great China Sales Business Group II/ (Sales Director, GE Healthcare) Strategic Development Business Group Yee-Min, Jen Chief Executive Officer Yi-Chun, Chen Vice President Oncology Business Group Finance Account
Slide 8: Exclusive Distributor for Top Global Brands
Exclusive Distributor for Top Global Brands Radiation Oncology Imaging System Ophthalmology & Neuroscience 8
Slide 9: Full Service Solution Provider “TurnKey Solutions”
Full Service Solution Provider“TurnKey Solutions” Manufacturer Technical & Service Product Strength Strength Top Global Brands Manufacturers CHC Healthcare Group • Radiation Certified Service Team • Neuroscience Revenue Technical .Site Planning Sharing Direct Selling • Ophthalmology Partnerships Ser
Slide 10: Product Mix
Product Mix Service revenue 9% Sales Revenue revenue Sharing 49% 42% 2016 Annual Value-Added Business Model 10
Slide 11: Operational Results
Company Operational Future Q&A Overview Results Guidance 11
Slide 12: Big Success in IBA Proton Therapy
Big Success in IBA Proton Therapy CHC signed both first official direct selling contract & first official revenue sharing contract in Taiwan!!! 12
Slide 13: IBA Proton Therapy
IBA Proton Therapy Unrivalled Experience 30+ 40+ 50,000+ 60%+ YEARS OF EXPERIENCE PARTNER INSTITUTIONS PATIENTS TREATED MARKET SHARE 13
Slide 14: IBA Proteus ONE
IBA Proteus ONE 14
Slide 15: IBA Proteus ONE
15 iO 5 CHC HEALTHCARE GROUP
Slide 16: Proton Design Flexibility
Proton Design Flexibility ProteusPLUS ProteusONE 1,800m2 300 m2 16
Slide 17: Precise Medicine
17 0" Electrons (21 MeV) | 100 - Relative dose [%] & 8 8 8 Carbon (270 MeV/u) | a Precise Medicine GN *£28 CHC HEALTHCARE GROUP
Slide 18: Pencil Beam Scanning by IBA
Pencil Beam Scanning by IBA 18
Slide 19: Pencil Beam Scanning by IBA
Pencil Beam Scanning by IBA 19
Slide 20: Intra-Operative Imaging
Intra-Operative Imaging SPY PINPOINT 20
Slide 21: Applications
Applications • Coronary Artery Bypass Grafting(CABG) • Cardiovascular Surgery • Plastic Surgery • Reconstructive Surgery • Microsurgery • Organ Transplantation • Gastrointestinal Surgery 21
Slide 22: Elekta - Versa HD
©Elekta Elekta - Versa HD —— iO 5 CHC HEALTHCARE GROUP
Slide 23: High definition by high modulation
High definition by high modulation • Precisely targeted • Intelligently controlled • Quality Assured 23
Slide 24: Monthly Sales
Monthly Sales 800,000 700,000 600,000 500,000 400,000 2016 2017 300,000 200,000 100,000 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YTD 2016 2017 YoY 2016 2017 YoY Jan 120,683 110,226 -8.66% Jul Feb 93,992 163,062 73.48% Aug Mar 144,171 299,674 107.86% Sep Apr 286,021 148,041 -48.24% Oct May N
Slide 25: Q1 Results
Q1 Results 600,000 2016 Q1 2017 Q1 550,000 500,000 Sales 360,596 572,962 450,000 Gross Profit 108,736 185,101 400,000 Gross Margin(%) 30.15% 32.31% 350,000 OP Profit 34,395 114,044 300,000 2016 Q1 OP Margin (%) 9.54% 19.90% 250,000 2017 Q1 200,000 Net Profit 9,128 72,148 150,000 Net Margin (%) 2.53%
Slide 26: Corporate Governance
Corporate Governance • 2016 Corporate Governance Evaluation -Ranking between top 6%~20% among all TWSE listed companies -Ranking between top 21%~35% in 2015 • Receive the Best Progress Award - only 10 companies are awarded among all TWSE listed companies 26
Slide 27: Corporate Social Responsibility Report
Corporate Social Responsibility Report 《2015 CHC CSR Report 》 • Release Date: Nov. 30, 2016 • Upload on Official Website and MOPS 《2016 CHC CSR Report 》 • Expected Release Date: Jun. 30, 2017 27
Slide 28: Future Guidance
Company Operational Future Q&A Overview Results Guidance 28
Slide 29: Entering Long-Term Care Market
Entering Long-Term Care Market 29
Slide 30: MoU Signed with Sakurajyuji Group
MoU Signed with Sakurajyuji Group 2016.10 .04 30
Slide 31: Sakurajyuji Group
Sakurajyuji Group • Name : Sakurajyuji Group • Date of Establish : 2006/07 • CEO : Mr. Tomoki Nishikawa • Number of employees :About 2,100 people • Headquarters : Kumamoto • Branches : Kumamoto, Tokyo, Fukuoka, Yatsushiro, Singapore & Philippines • Major Business : Running Hospital and Long-term Car
Slide 32: Elder-Friendly Design
, =a a , me ee ee ee \ se a ee es , 2 a oe = on on peau co
Slide 33: Joint Organizer of International Forum
Joint Organizer of International Forum Attention of the societyXCHC’s strong appeal • 2017 International Elderly Care Industry Leaders Forum” • Global VIP Speakers from USA, Japan and Korea • The combination of industry, official, academic and medical • Over 1000 attendees • New Perspective, New Ins
Slide 34: om R: ne ~
om R: ne ~
Slide 35: Introduce New Product
Introduce New Product 35
Slide 36: Elekta MR-Linac
Elekta MR-Linac a GElekta
Slide 37: MR Adaptive RT
MR Adaptive RT Soft Tissue Imaging with Diagnostic Quality + HD Dynamic Radiosurgery 37
Slide 38: Product Diversification
Products and Geography Expansion Long-Term Care Business Cancer Center Consulting & Management New (Taiwan、China、Southeast Asia) Products Product Diversification IBA Proton Therapy Novadaq Fluorescence Imaging Technology (Greater China) White Essence Dental Clinic (Exclusive Greater China Distributo
Slide 39: Be the Leading Medical Equipment Full Service Solutions Provider in Asia-Pacific
Headquarter in Subsidiary in Beijing Taiwan Subsidiary in Guangzhou Indonesia Be the Leading Medical Equipment Full Service Solutions Provider in Asia-Pacific 39
Slide 40: Company Operational Future
Company Operational Future Overview Results Guidance Q&A 40
Slide 41: Thank you
Thank you 41
CHC Healthcare Group — 2017 Institutional Investor Conference on 6ix